However, several alternative or additional mechanisms have been proposed, including the tumor-selective accumulation of several different HSP90 inhibitors as well as their much higher affinity for the hyper-activated HSP90 complexes specifically observed in tumor cells (13, 15, 16). This evidence concerns the gene HSP90AB1 and neoplasm.